Erratum: Wnt-pathway inhibitors with selective activity against triple-negative breast cancer: From thienopyrimidine to quinazoline inhibitors

Erratum: Wnt-pathway inhibitors with selective activity against triple-negative breast cancer: From thienopyrimidine to quinazoline inhibitors

Bibliographic Details
Main Author:	Frontiers Production Office
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-03-01
Series:	Frontiers in Pharmacology
Subjects:	Wnt signaling triple-negative breast cancer β-catenin cancer survival medicinal chemistry structure activity relationship
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2023.1173490/full

Similar Items

Wnt-pathway inhibitors with selective activity against triple-negative breast cancer: From thienopyrimidine to quinazoline inhibitors
by: Cédric Boudou, et al.
Published: (2022-10-01)

Countering Triple Negative Breast Cancer via Impeding Wnt/β-Catenin Signaling, a Phytotherapeutic Approach
by: Laleh Arzi, et al.
Published: (2022-08-01)

Fbxw7 suppresses carcinogenesis and stemness in triple-negative breast cancer through CHD4 degradation and Wnt/β-catenin pathway inhibition
by: Guodong Xiao, et al.
Published: (2024-01-01)

AHNAK suppresses tumour proliferation and invasion by targeting multiple pathways in triple-negative breast cancer
by: Bo Chen, et al.
Published: (2017-05-01)

Nek2B activates the wnt pathway and promotes triple-negative breast cancer chemothezrapy-resistance by stabilizing β-catenin
by: Honghong Shen, et al.
Published: (2019-06-01)

Coordinated regulation of WNT/β-catenin, c-Met, and integrin signalling pathways by miR-193b controls triple negative breast cancer metastatic traits
by: Chiara Giacomelli, et al.
Published: (2021-12-01)

MiR-27a-3p Targeting GSK3β Promotes Triple-Negative Breast Cancer Proliferation and Migration Through Wnt/β-Catenin Pathway
by: Wu R, et al.
Published: (2020-07-01)

Targeting Triple Negative Breast Cancer Stem Cells by Heat Shock Protein 70 Inhibitors
by: Chia-Hung Tsai, et al.
Published: (2022-10-01)

CUEDC2 Drives β-Catenin Nuclear Translocation and Promotes Triple-Negative Breast Cancer Tumorigenesis
by: Shuyan Han, et al.
Published: (2022-09-01)

Novel Thienopyrimidine Derivative, RP-010, Induces β-Catenin Fragmentation and Is Efficacious against Prostate Cancer Cells
by: Haneen Amawi, et al.
Published: (2019-05-01)

Targeting Wnt Signaling for Gastrointestinal Cancer Therapy: Present and Evolving Views
by: Moon Jong Kim, et al.
Published: (2020-12-01)

Natural compounds: Wnt pathway inhibitors with therapeutic potential in lung cancer
by: Xuetong Shen, et al.
Published: (2023-09-01)

Wnt Signaling Inhibitors and Their Promising Role in Tumor Treatment
by: Nives Pećina-Šlaus, et al.
Published: (2023-04-01)

AFAP1-AS1 Promotes Epithelial-Mesenchymal Transition and Tumorigenesis Through Wnt/β-Catenin Signaling Pathway in Triple-Negative Breast Cancer
by: Kaiming Zhang, et al.
Published: (2018-11-01)

Kinesin family member 23, regulated by FOXM1, promotes triple negative breast cancer progression via activating Wnt/β-catenin pathway
by: Zhi Li, et al.
Published: (2022-05-01)

Role of microRNA/lncRNA Intertwined With the Wnt/β-Catenin Axis in Regulating the Pathogenesis of Triple-Negative Breast Cancer
by: Xue Hu, et al.
Published: (2022-06-01)

β-catenin inhibitors in cancer therapeutics: intricacies and way forward
by: Arundhathi Dev, et al.
Published: (2023-12-01)

RX-5902, a novel β-catenin modulator, potentiates the efficacy of immune checkpoint inhibitors in preclinical models of triple-negative breast Cancer
by: John J. Tentler, et al.
Published: (2020-11-01)

Wnt and Vitamin D at the Crossroads in Solid Cancer
by: José Manuel González-Sancho, et al.
Published: (2020-11-01)

Hyperin Controls the Development and Therapy of Gastric Cancer via Regulating Wnt/β-Catenin Signaling
by: Ping MH
Published: (2020-11-01)

SEPTIN3 Promotes Progression of Triple-Negative Breast Cancer via Activating Wnt Pathway
by: Wang GZ, et al.
Published: (2023-09-01)

Dual inhibition of Wnt and Yes‐associated protein signaling retards the growth of triple‐negative breast cancer in both mesenchymal and epithelial states
by: Andrew Sulaiman, et al.
Published: (2018-04-01)

The Wnt Signalling Pathway: A Tailored Target in Cancer
by: Malvina Koni, et al.
Published: (2020-10-01)

Wnt Signaling in the Gastrointestinal Tract in Health and Disease
by: Negar Taheri, et al.
Published: (2023-02-01)

Clinical significancy of WNT pathway inhibition in various cancers
by: Patryk Rogaczewski, et al.
Published: (2022-11-01)

Triple-Negative Breast Cancer Survival in Iranian Patients
by: Mahdi Aghili, et al.
Published: (2013-08-01)

The Significance of the Dysregulation of Canonical Wnt Signaling in Head and Neck Squamous Cell Carcinomas
by: Jarosław Paluszczak
Published: (2020-03-01)

The Role of miR-640: A Potential Suppressor in Breast Cancer via Wnt7b/β-catenin Signaling Pathway
by: Chun Tang, et al.
Published: (2021-04-01)

A Review of the Role of Wnt in Cancer Immunomodulation
by: Whitney N. Goldsberry, et al.
Published: (2019-06-01)

The interplay between non-coding RNAs and Wnt/β-catenin signaling pathway in urinary tract cancers
by: Farzad Rahmani, et al.
Published: (2022-10-01)

Wnt and β-Catenin Signaling in the Bone Metastasis of Prostate Cancer
by: Zachary Kaplan, et al.
Published: (2021-10-01)

The Outcome of Patients with Triple Negative Breast Cancer: The Turkish Oncology Group Experience
by: Yeşim Eralp, et al.
Published: (2014-10-01)

Wnt/β-Catenin Inhibition Disrupts Carboplatin Resistance in Isogenic Models of Triple-Negative Breast Cancer
by: Willy Antoni Abreu de Oliveira, et al.
Published: (2021-07-01)

Effect of Yes-associated Protein Knockdown on Apoptosis of Gastric Cancer BGC823 Cells Through Wnt/β-catenin Signaling Pathway
by: ZHANG Wei, et al.
Published: (2018-11-01)

A Cell Model Suitable for a High-Throughput Screening of Inhibitors of the Wnt/β-Catenin Pathway
by: Marina Grimaldi, et al.
Published: (2018-10-01)

Targeting Oncogenic Wnt/β-Catenin Signaling in Adrenocortical Carcinoma Disrupts ECM Expression and Impairs Tumor Growth
by: Morgan K. Penny, et al.
Published: (2023-07-01)

Wnt Signaling in the Development of Bone Metastasis
by: Noa Ben-Ghedalia-Peled, et al.
Published: (2022-12-01)

The PMA phorbol ester tumor promoter increases canonical Wnt signaling via macropinocytosis
by: Nydia Tejeda-Munoz, et al.
Published: (2023-10-01)

Corrigendum: AFAP1-AS1 Promotes Epithelial-Mesenchymal Transition and Tumorigenesis Through Wnt/β-Catenin Signaling Pathway in Triple-Negative Breast Cancer
by: Kaiming Zhang, et al.
Published: (2020-07-01)

The Role of WNT Pathway Mutations in Cancer Development and an Overview of Therapeutic Options
by: Wibke Groenewald, et al.
Published: (2023-03-01)